Shire Pharmaceuticals Group Plc
Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
Dublin (ots/PRNewswire) - ? Shire plc , the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire FerroKin BioSciences, Inc., for an upfront payment of $100 million, payable in cash at closing, plus potential post-closing milestone payments of up to $225 million, depending upon the achievement of certain clinical development, ...
plus